|
GB0617948D0
|
|
Histamine binding protein
|
|
GB0617734D0
|
|
Method of treating peripheral nerve disorders
|
|
GB0617735D0
|
|
Method of treating respiratory disorders
|
|
GB0611579D0
|
|
Histamine binding protein
|
|
GB0518443D0
|
|
Method of treating myasthenia gravis
|
|
CA2526083A1
|
|
Complement inhibitors
|
|
GB0327386D0
|
|
Complement inhibitors
|
|
GB0312619D0
|
|
Complement inhibitors
|
|
GB0307544D0
|
|
Treatment method
|
|
GB0209249D0
|
|
Anticoagulants
|
|
GB0206575D0
|
|
Vaccine
|
|
GB0124137D0
|
|
Vaccine
|
|
GB0115363D0
|
|
Ion channel modulators
|
|
CN1438896A
|
|
The vaccine that contains a kind of tick cement protein
|
|
AU3205201A
|
|
Cytokine inhibitory molecules from tick salivary glands
|
|
AU2209901A
|
|
Screening method
|
|
GB0031708D0
|
|
Regulator molecules
|
|
GB0028606D0
|
|
Vaccine composition
|
|
AU6713900A
|
|
Treatment of conjunctivitis
|
|
WO0116164A2
|
|
Treatment of allergic rhinitis
|
